These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 7641219

  • 1. Antibody-independent phagocytosis of tumor cells by human monocyte-derived macrophages cultured in recombinant macrophage colony-stimulating factor.
    Munn DH, Cheung NK.
    Cancer Immunol Immunother; 1995 Jul; 41(1):46-52. PubMed ID: 7641219
    [Abstract] [Full Text] [Related]

  • 2. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon.
    Munn DH, Armstrong E.
    Cancer Res; 1993 Jun 01; 53(11):2603-13. PubMed ID: 8495423
    [Abstract] [Full Text] [Related]

  • 3. Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays.
    Munn DH, Cheung NK.
    J Exp Med; 1989 Aug 01; 170(2):511-26. PubMed ID: 2526848
    [Abstract] [Full Text] [Related]

  • 4. Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor.
    Munn DH, Cheung NK.
    J Exp Med; 1990 Jul 01; 172(1):231-7. PubMed ID: 2193096
    [Abstract] [Full Text] [Related]

  • 5. Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210.
    Watanabe M, Wallace PK, Keler T, Deo YM, Akewanlop C, Hayes DF.
    Breast Cancer Res Treat; 1999 Feb 01; 53(3):199-207. PubMed ID: 10369066
    [Abstract] [Full Text] [Related]

  • 6. Macrophage colony-stimulating factor enhancement of antibody-dependent cellular cytotoxicity against human colon carcinoma cells.
    Qi CF, Nieroda C, De Filippi R, Greiner JW, Correale P, Schlom J, Tsang KY.
    Immunol Lett; 1995 Feb 01; 47(1-2):15-24. PubMed ID: 8537095
    [Abstract] [Full Text] [Related]

  • 7. Colony-stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumour cells.
    Baldwin GC, Chung GY, Kaslander C, Esmail T, Reisfeld RA, Golde DW.
    Br J Haematol; 1993 Apr 01; 83(4):545-53. PubMed ID: 7686031
    [Abstract] [Full Text] [Related]

  • 8. Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells.
    Rüegg SJ, Jungi TW.
    Immunology; 1988 Mar 01; 63(3):513-20. PubMed ID: 2965100
    [Abstract] [Full Text] [Related]

  • 9. M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.
    Leidi M, Gotti E, Bologna L, Miranda E, Rimoldi M, Sica A, Roncalli M, Palumbo GA, Introna M, Golay J.
    J Immunol; 2009 Apr 01; 182(7):4415-22. PubMed ID: 19299742
    [Abstract] [Full Text] [Related]

  • 10. Peripheral blood monocytes derived from HIV+ individuals mediate antibody-dependent cellular cytotoxicity (ADCC).
    Jewett A, Bonavida B.
    Clin Immunol Immunopathol; 1990 Feb 01; 54(2):192-9. PubMed ID: 2104787
    [Abstract] [Full Text] [Related]

  • 11. Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibody.
    Akewanlop C, Watanabe M, Singh B, Walker M, Kufe DW, Hayes DF.
    Cancer Res; 2001 May 15; 61(10):4061-5. PubMed ID: 11358826
    [Abstract] [Full Text] [Related]

  • 12. Macrophage colony-stimulating factor enhances monocyte and macrophage antibody-dependent cell-mediated cytotoxicity.
    Mufson RA, Aghajanian J, Wong G, Woodhouse C, Morgan AC.
    Cell Immunol; 1989 Mar 15; 119(1):182-92. PubMed ID: 2646026
    [Abstract] [Full Text] [Related]

  • 13. Role of low-affinity Fc receptors in antibody-dependent tumor cell phagocytosis by human monocyte-derived macrophages.
    Munn DH, McBride M, Cheung NK.
    Cancer Res; 1991 Feb 15; 51(4):1117-23. PubMed ID: 1825476
    [Abstract] [Full Text] [Related]

  • 14. Myeloid cells as effector cells for monoclonal antibody therapy of cancer.
    Braster R, O'Toole T, van Egmond M.
    Methods; 2014 Jan 01; 65(1):28-37. PubMed ID: 23811299
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage-mediated antibody dependent cellular cytotoxicity.
    Liesveld JL, Frediani KE, Winslow JM, Duerst RE, Abboud CN.
    J Cell Biochem; 1991 Apr 01; 45(4):381-90. PubMed ID: 1675219
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of macrophage antibody-dependent killing of tumor targets by recombinant lymphokine factors and M-CSF.
    Nakoinz I, Ralph P.
    Cell Immunol; 1988 Oct 15; 116(2):331-40. PubMed ID: 2460249
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.